{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:59:14Z","timestamp":1793865554583,"version":"4.6.1"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"4","funder":[{"DOI":"10.13039\/100000025","name":"National Institutes of Mental Health","doi-asserted-by":"crossref","award":["R21MH127498"],"award-info":[{"award-number":["R21MH127498"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"National Institutes of Mental Health","doi-asserted-by":"crossref","award":["R21MH127498-01S1"],"award-info":[{"award-number":["R21MH127498-01S1"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Baszucki Group"},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","award":["CX002519"],"award-info":[{"award-number":["CX002519"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Career Development Awards","award":["CX002355"],"award-info":[{"award-number":["CX002355"]}]},{"name":"Career Development Awards","award":["CX002457"],"award-info":[{"award-number":["CX002457"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Hypothesis<\/jats:title>\n                    <jats:p>Psychiatric medications contribute to high rates of metabolic dysfunction in psychotic disorders. Ketogenic diets reduce metabolic syndrome, have anticonvulsant effects in epilepsy, and may improve symptoms of schizophrenia and bipolar disorder. We report the first randomized controlled trial to assess effects of ketogenic diets on metabolism, psychiatric symptoms, and cognition in people with schizophrenia-spectrum and bipolar-1 disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Methods<\/jats:title>\n                    <jats:p>Participants were randomized to a ketogenic diet (KETO; n\u00a0=\u200928) or diet-as-usual (DAU; n\u00a0=\u200930) for 1 month. Partway through the trial, a KETO extension was offered to both groups, resulting in a sub-group who completed the diet for 4\u00a0months (n\u00a0=\u200925). We assessed changes in metabolic health, clinical symptoms, and cognition after 1 month (KETO versus DAU) and after 4\u00a0months (KETO versus baseline).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Results<\/jats:title>\n                    <jats:p>KETO participants\u2019 daily ketone levels surpassed the standard ketosis threshold. Relative to DAU, KETO participants showed reductions in weight (Padj\u00a0&amp;lt;\u2009 .001), hemoglobin A1c (Padj\u00a0= .05), and insulin resistance (Padj\u00a0=\u2009.05). Clinical symptoms (positive, negative, depression) and cognitive performance improved after 4\u00a0months on the KETO (all P-values &amp;lt; .001). Increased blood ketone levels in KETO participants correlated with improvements in pre-diabetic markers and depressive symptoms (all P-values &amp;lt; .001). Reduced weight following the KETO was unrelated to metabolic and symptom improvements.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We demonstrate feasibility of administering a KETO in outpatients with schizophrenia and bipolar-1 disorder. Participants showed improvement in metabolic health, cognitive performance, and clinical symptoms. Improvement in depressive symptoms was associated with ketosis rather than weight loss, implicating ketosis as the therapeutic mechanism.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/schbul\/sbag082","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:02:12Z","timestamp":1783486932000},"source":"Crossref","is-referenced-by-count":6,"title":["Metabolic Improvements with a Ketogenic Diet Correlate with Symptom Improvement in Psychosis: A Randomized Controlled Trial"],"prefix":"10.1093","volume":"52","author":[{"given":"Samantha V","family":"Abram","sequence":"first","affiliation":[{"name":"Mental Health Services, San Francisco VA Medical Center, 4150 Clement St , San Francisco, CA 94121 ,","place":["United States"]},{"name":"Department of Psychiatry and Behavioral Sciences, University of California, San Francisco , San Francisco, CA 94143 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette M","family":"Kyner","sequence":"additional","affiliation":[{"name":"Mental Health Services, San Francisco VA Medical Center, 4150 Clement St , San Francisco, CA 94121 ,","place":["United States"]},{"name":"Department of Psychiatry and Behavioral Sciences, University of California, San Francisco , San Francisco, CA 94143 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Vu","sequence":"additional","affiliation":[{"name":"Mental Health Services, San Francisco VA Medical Center, 4150 Clement St , San Francisco, CA 94121 ,","place":["United States"]},{"name":"Department of Psychiatry and Behavioral Sciences, University of California, San Francisco , San Francisco, CA 94143 ,","place":["United States"]},{"name":"Northern California Institute for Research and Education , San Francisco, CA 94121 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zanib","family":"Naeem","sequence":"additional","affiliation":[{"name":"Mental Health Services, San Francisco VA Medical Center, 4150 Clement St , San Francisco, CA 94121 ,","place":["United States"]},{"name":"Department of Psychiatry and Behavioral Sciences, University of California, San Francisco , San Francisco, CA 94143 ,","place":["United States"]},{"name":"Northern California Institute for Research and Education , San Francisco, CA 94121 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shebani","family":"Sethi","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine , Stanford, CA 94305 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3597-6126","authenticated-orcid":false,"given":"Michael S","family":"Jacob","sequence":"additional","affiliation":[{"name":"Mental Health Services, San Francisco VA Medical Center, 4150 Clement St , San Francisco, CA 94121 ,","place":["United States"]},{"name":"Department of Psychiatry and Behavioral Sciences, University of California, San Francisco , San Francisco, CA 94143 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna L","family":"Fryer","sequence":"additional","affiliation":[{"name":"Mental Health Services, San Francisco VA Medical Center, 4150 Clement St , San Francisco, CA 94121 ,","place":["United States"]},{"name":"Department of Psychiatry and Behavioral Sciences, University of California, San Francisco , San Francisco, CA 94143 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H","family":"Mathalon","sequence":"additional","affiliation":[{"name":"Mental Health Services, San Francisco VA Medical Center, 4150 Clement St , San Francisco, CA 94121 ,","place":["United States"]},{"name":"Department of Psychiatry and Behavioral Sciences, University of California, San Francisco , San Francisco, CA 94143 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6500-6548","authenticated-orcid":false,"given":"Judith M","family":"Ford","sequence":"additional","affiliation":[{"name":"Mental Health Services, San Francisco VA Medical Center, 4150 Clement St , San Francisco, CA 94121 ,","place":["United States"]},{"name":"Department of Psychiatry and Behavioral Sciences, University of California, San Francisco , San Francisco, CA 94143 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"2026081405121837200_ref1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s11892-019-1220-8","article-title":"Association between antipsychotic medication use and diabetes","volume":"19","author":"Holt","year":"2019","journal-title":"Curr Diab Rep"},{"key":"2026081405121837200_ref2","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1176\/appi.ajp.2017.16121358","article-title":"Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors","volume":"174","author":"Leucht","year":"2017","journal-title":"AJP."},{"key":"2026081405121837200_ref3","doi-asserted-by":"publisher","first-page":"103192","DOI":"10.1016\/j.ajp.2022.103192","article-title":"Metabolic syndrome and cardiovascular risk between clozapine and non-clozapine antipsychotic users with schizophrenia","volume":"74","author":"Quek","year":"2022","journal-title":"Asian J Psychiatr"},{"key":"2026081405121837200_ref4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/JCP.0000000000002058","article-title":"Metabolic problems among people with treatment-resistant schizophrenia are not unique to clozapine","volume":"45","author":"John","year":"2025","journal-title":"J Clin Psychopharmacol"},{"key":"2026081405121837200_ref5","doi-asserted-by":"publisher","first-page":"e220009","DOI":"10.20900\/jpbs.20220009","article-title":"The role of ketogenic metabolic therapy on the brain in serious mental illness: a review","volume":"7","author":"Sethi","year":"2022","journal-title":"J Psychiatr Brain Sci"},{"key":"2026081405121837200_ref6","doi-asserted-by":"publisher","first-page":"115866","DOI":"10.1016\/j.psychres.2024.115866","article-title":"Ketogenic diet intervention on metabolic and psychiatric health in bipolar and schizophrenia: a pilot trial","volume":"335","author":"Sethi","year":"2024","journal-title":"Psychiatry Res"},{"key":"2026081405121837200_ref7","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.schres.2017.01.053","article-title":"Ketogenic diet in the treatment of schizoaffective disorder: two case studies","volume":"189","author":"Palmer","year":"2017","journal-title":"Schizophr Res"},{"key":"2026081405121837200_ref8","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.schres.2019.03.019","article-title":"The ketogenic diet and remission of psychotic symptoms in schizophrenia: two case studies","volume":"208","author":"Palmer","year":"2019","journal-title":"Schizophr Res"},{"key":"2026081405121837200_ref9","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.jacc.2010.05.034","article-title":"The metabolic syndrome and cardiovascular risk","volume":"56","author":"Mottillo","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026081405121837200_ref10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.schres.2005.12.855","article-title":"Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication","volume":"83","author":"De Hert","year":"2006","journal-title":"Schizophr Res"},{"key":"2026081405121837200_ref11","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3389\/fpsyt.2018.00621","article-title":"Increased risk of metabolic syndrome in antidepressants users: a mini review","volume":"9","author":"Gramaglia","year":"2018","journal-title":"Front Psychiatry"},{"key":"2026081405121837200_ref12","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1017\/S0033291724000345","article-title":"Neurocognitive correlates of metabolic dysregulation in individuals with mood disorders: a systematic review and meta-analysis","volume":"54","author":"Maksyutynska","year":"2024","journal-title":"Psychol Med"},{"key":"2026081405121837200_ref13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.31887\/DCNS.2018.20.1\/bpenninx","article-title":"Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications","volume":"20","author":"Penninx","year":"2018","journal-title":"Dialogues Clin Neurosci"},{"key":"2026081405121837200_ref14","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jpsychores.2015.02.010","article-title":"Metabolic syndrome in patients with bipolar disorder: comparison with major depressive disorder and non-psychiatric controls","volume":"78","author":"Silarova","year":"2015","journal-title":"J Psychosom Res"},{"key":"2026081405121837200_ref15","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1017\/S0033291721002853","article-title":"Metabolic syndrome in antipsychotic-na\u00efve patients with first-episode psychosis: a systematic review and meta-analysis","volume":"51","author":"Garrido-Torres","year":"2021","journal-title":"Psychol Med"},{"key":"2026081405121837200_ref16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1001\/jamapsychiatry.2016.3803","article-title":"Impaired glucose homeostasis in first-episode schizophrenia: a systematic review and meta-analysis","volume":"74","author":"Pillinger","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"2026081405121837200_ref17","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/bdi.12505","article-title":"Twenty-year progression of body mass index in a county-wide cohort of people with schizophrenia and bipolar disorder identified at their first episode of psychosis","volume":"19","author":"Strassnig","year":"2017","journal-title":"Bipolar Disord"},{"key":"2026081405121837200_ref18","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s13679-024-00589-6","article-title":"Diet quality scores, obesity and metabolic syndrome in children and adolescents: a systematic review and meta-analysis","volume":"13","author":"Larruy-Garc\u00eda","year":"2024","journal-title":"Curr Obes Rep"},{"key":"2026081405121837200_ref19","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.3390\/nu14214519","article-title":"Diet, exercise, and the metabolic syndrome: enrollment of the mitochondrial machinery","volume":"14","author":"Silvestri","year":"2022","journal-title":"Nutrients."},{"key":"2026081405121837200_ref20","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00406-022-01442-4","article-title":"Lifestyle behaviors, metabolic disturbances, and weight gain in psychiatric inpatients treated with weight gain-associated medication","volume":"273","author":"Simon","year":"2023","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2026081405121837200_ref21","doi-asserted-by":"publisher","first-page":"6700","DOI":"10.3390\/ijerph17186700","article-title":"Risk factors of metabolic syndrome in community-dwelling people with schizophrenia","volume":"17","author":"Sun","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"2026081405121837200_ref22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/nutrit\/nuad071","article-title":"Effect of the ketogenic diet as a treatment for refractory epilepsy in children and adolescents: a systematic review of reviews","volume":"82","author":"D\u00edez-Arroyo","year":"2024","journal-title":"Nutr Rev"},{"key":"2026081405121837200_ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2019.106588","article-title":"History of dietary treatment from Wilder\u2019s hypothesis to the first open studies in the 1920s","volume":"101","author":"H\u00f6hn","year":"2019","journal-title":"Epilepsy Behav"},{"key":"2026081405121837200_ref24","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.1017\/S003329172200174X","article-title":"Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of18 FDG-PET studies in schizophrenia","volume":"53","author":"Townsend","year":"2023","journal-title":"Psychol Med"},{"key":"2026081405121837200_ref25","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3390\/biom10030384","article-title":"Oxidative-antioxidant imbalance and impaired glucose metabolism in schizophrenia","volume":"10","author":"Bryll","year":"2020","journal-title":"Biomolecules."},{"key":"2026081405121837200_ref26","doi-asserted-by":"publisher","first-page":"732120","DOI":"10.3389\/fnmol.2021.732120","article-title":"Ketone bodies in the brain beyond fuel metabolism: from excitability to gene expression and cell Signaling","volume":"14","author":"Garc\u00eda-Rodr\u00edguez","year":"2021","journal-title":"Front Mol Neurosci"},{"key":"2026081405121837200_ref27","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3390\/metabo15080508","article-title":"Ketogenic metabolism in neurodegenerative diseases: mechanisms of action and therapeutic potential","volume":"15","author":"Paw\u0142owska","year":"2025","journal-title":"Metabolites."},{"key":"2026081405121837200_ref28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.neuron.2010.09.002","article-title":"Metabolic control of vesicular glutamate transport and release","volume":"68","author":"Juge","year":"2010","journal-title":"Neuron."},{"key":"2026081405121837200_ref29","doi-asserted-by":"publisher","first-page":"178409","DOI":"10.1016\/j.ejphar.2025.178409","article-title":"Protective effects of \u03b2-hydroxybutyrate against N-methyl-D-aspartic acid-induced excitotoxic retinal injury in rats","volume":"1010","author":"Endo","year":"2026","journal-title":"Eur J Pharmacol"},{"key":"2026081405121837200_ref30","doi-asserted-by":"publisher","first-page":"103959","DOI":"10.1016\/j.mcn.2024.103959","article-title":"\u03b2-Hydroxybutyrate enhances astrocyte glutamate uptake through EAAT1 expression regulation","volume":"131","author":"Shang","year":"2024","journal-title":"Mol Cell Neurosci"},{"key":"2026081405121837200_ref31","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3390\/ijms25010124","article-title":"Molecular mechanisms of neuroprotection by ketone bodies and ketogenic diet in cerebral ischemia and neurodegenerative diseases","volume":"25","author":"Jang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026081405121837200_ref32","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1192\/bjo.2024.841","article-title":"A pilot study of a ketogenic diet in bipolar disorder: clinical, metabolic and magnetic resonance spectroscopy findings","volume":"11","author":"Campbell","year":"2025","journal-title":"BJPsych Open"},{"key":"2026081405121837200_ref33","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/s41398-025-03544-8","article-title":"A pilot study examining a ketogenic diet as an adjunct therapy in college students with major depressive disorder","volume":"15","author":"Decker","year":"2025","journal-title":"Transl Psychiatry"},{"key":"2026081405121837200_ref34","doi-asserted-by":"publisher","first-page":"951376","DOI":"10.3389\/fpsyt.2022.951376","article-title":"The ketogenic diet for refractory mental illness: a retrospective analysis of 31 inpatients","volume":"13","author":"Danan","year":"2022","journal-title":"Front Psychiatry"},{"key":"2026081405121837200_ref35","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2025.4431","article-title":"A ketogenic diet for treatment-resistant depression: a randomized clinical trial","volume":"83","author":"Gao","year":"2026","journal-title":"JAMA Psychiatry"},{"key":"2026081405121837200_ref36","volume-title":"Structured Clinical Interview for DSM-5\u2014 Research Version (SCID-5 for DSM-5, Research Version; SCID-5-RV, Version 1.0.0)","author":"First","year":"2015"},{"key":"2026081405121837200_ref37","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.biopsych.2004.06.023","article-title":"Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria","volume":"56","author":"Green","year":"2004","journal-title":"Biol Psychiatry"},{"key":"2026081405121837200_ref38","author":"Andreasen","year":"1984"},{"key":"2026081405121837200_ref39","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1192\/S0007125000291496","article-title":"The scale for the assessment of negative symptoms (SANS): conceptual and theoretical foundations","volume":"7","author":"Andreasen","year":"1989","journal-title":"Br J Psychiatry Suppl"},{"key":"2026081405121837200_ref40","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"2026081405121837200_ref41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13063-018-3108-3","article-title":"The correlation between baseline score and post-intervention score, and its implications for statistical analysis","volume":"20","author":"Clifton","year":"2019","journal-title":"Trials."},{"key":"2026081405121837200_ref42","doi-asserted-by":"publisher","first-page":"10429","DOI":"10.3390\/ijerph191610429","article-title":"Ketogenic diet benefits to weight loss, Glycemic control, and lipid profiles in overweight patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trails","volume":"19","author":"Zhou","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"2026081405121837200_ref43","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s41398-022-02002-z","article-title":"Metabolic disturbances, hemoglobin A1c, and social cognition impairment in schizophrenia spectrum disorders","volume":"12","author":"Tang","year":"2022","journal-title":"Transl Psychiatry"},{"key":"2026081405121837200_ref44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.comppsych.2015.07.003","article-title":"Gender differences in cognitive deficits in schizophrenia with and without diabetes","volume":"63","author":"Zhang","year":"2015","journal-title":"Compr Psychiatry"},{"key":"2026081405121837200_ref45","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1080\/1028415X.2022.2143609","article-title":"Effects of the ketogenic diet on cognition: a systematic review","volume":"26","author":"Chinna-Meyyappan","year":"2023","journal-title":"Nutr Neurosci"},{"key":"2026081405121837200_ref46","doi-asserted-by":"publisher","first-page":"119652","DOI":"10.1016\/j.jad.2025.119652","article-title":"Association between dietary ketogenic ratio and depressive symptoms: a population-based cross-sectional study using 2007-2018 NHANES data","volume":"389","author":"Zhuang","year":"2025","journal-title":"J Affect Disord"},{"key":"2026081405121837200_ref47","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/schbul\/sbaa094","article-title":"The psychopathology and neuroanatomical markers of depression in early psychosis","volume":"47","author":"Upthegrove","year":"2021","journal-title":"Schizophr Bull"},{"key":"2026081405121837200_ref48","doi-asserted-by":"publisher","first-page":"101353","DOI":"10.1016\/j.dcn.2024.101353","article-title":"Limitations of two time point data for understanding individual differences in longitudinal modeling - what can difference reveal about change?","volume":"66","author":"Parsons","year":"2024","journal-title":"Dev Cogn Neurosci"},{"key":"2026081405121837200_ref49","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.3390\/nu15153368","article-title":"The ketogenic diet and cardiovascular diseases","volume":"15","author":"Dy\u0144ka","year":"2023","journal-title":"Nutrients."},{"key":"2026081405121837200_ref50","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.cmet.2016.12.022","article-title":"Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics","volume":"25","author":"Puchalska","year":"2017","journal-title":"Cell Metab"},{"key":"2026081405121837200_ref51","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ajcnut.2024.04.021","article-title":"Impact of the ketogenic diet as a dietary approach on cardiovascular disease risk factors: a meta-analysis of randomized clinical trials","volume":"120","author":"Wang","year":"2024","journal-title":"Am J Clin Nutr"},{"key":"2026081405121837200_ref52","doi-asserted-by":"publisher","first-page":"112804","DOI":"10.1016\/j.nut.2025.112804","article-title":"Beyond epilepsy management: a narrative review of the health effects of ketogenic diets","volume":"137","author":"Chamma","year":"2025","journal-title":"Nutrition."},{"key":"2026081405121837200_ref53","doi-asserted-by":"publisher","first-page":"1444483","DOI":"10.3389\/fnut.2024.1444483","article-title":"The effects of ketogenic metabolic therapy on mental health and metabolic outcomes in schizophrenia and bipolar disorder: a randomized controlled clinical trial protocol","volume":"11","author":"Longhitano","year":"2024","journal-title":"Front Nutr"}],"container-title":["Schizophrenia Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/52\/4\/sbag082\/68702857\/sbag082.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/52\/4\/sbag082\/68702857\/sbag082.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T09:14:45Z","timestamp":1786698885000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article\/doi\/10.1093\/schbul\/sbag082\/8725541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7,3]]}},"URL":"https:\/\/doi.org\/10.1093\/schbul\/sbag082","relation":{},"ISSN":["0586-7614","1745-1701"],"issn-type":[{"value":"0586-7614","type":"print"},{"value":"1745-1701","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,7]]},"article-number":"sbag082"}}